James J. Dignam

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison, Andy Trotti, Jonathan Harris et al. · The Lancet · 2018 · 1.3K citations

Medicine, Oncology, Radiation Oncology +6

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

Bernard Fisher, James J. Dignam, Norman Wolmark et al. · Journal of Clinical Oncology · 1998 · 896 citations

Medicine, Oncology, Surgery +16

Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors

Bernard Fisher, James J. Dignam, John Bryant et al. · JNCI Journal of the National Cancer Institute · 1996 · 869 citations · Full text

Medicine, Gynecology, Oncology +16

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

Irene Wapnir, James J. Dignam, Bernard Fisher et al. · JNCI Journal of the National Cancer Institute · 2011 · 780 citations · Full text

Medicine, Oncology, Surgery +12

Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less

Bernard Fisher, John Bryant, James J. Dignam et al. · Journal of Clinical Oncology · 2002 · 696 citations

Medicine, Oncology, Radiation Oncology +17